دورية أكاديمية

Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?

التفاصيل البيبلوغرافية
العنوان: Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?
المؤلفون: van Tilborg, Theodora C., Broekmans, Frank J., Pijpe, Anouk, Schrijver, Lieske H., Mooij, Thea M., Oosterwijk, Jan C., Verhoef, Senno, Gómez Garcia, Encarna B., van Zelst-Stams, Wendy A., Adank, Muriel A., van Asperen, Christi J., van Doorn, Helena C., van Os, Theo A., Bos, Anna M., Rookus, Matti A., Ausems, Margreet G.
المصدر: Menopause ; volume 23, issue 8, page 903-910 ; ISSN 1072-3714 1530-0374
بيانات النشر: Ovid Technologies (Wolters Kluwer Health)
سنة النشر: 2016
الوصف: Objective: It has been hypothesized that BRCA1/2 mutation carriers have an earlier age at natural menopause (ANM), although to date findings are inconclusive. This study assessed the influence of BRCA mutation status on ANM, and aimed to explore the reasons of inconsistency in the literature. Methods: Cross-sectional assessment from an ongoing nationwide cohort study among members of BRCA1/2 mutated families. Information was obtained by a standardized questionnaire. Kaplan-Meier curves were constructed, and Cox regression was used to assess the association between BRCA1/2 mutation status and ANM. Adjustments were made for birth cohort, family, smoking, use of hormonal contraceptives, and parity. Results: A total of 1,208 BRCA1/2 mutation carriers and 2,211 proven noncarriers were included. Overall, no association was found between BRCA1/2 mutation status and ANM (adjusted hazard ratio [HR] = 1.06 [95% CI, 0.87-1.30]). We examined if the null finding was due to informative censoring by uptake of risk-reducing salpingo-oophorectomy. Indeed, within the oldest birth cohort, in which the percentage of surgical menopause events was lowest and comparable between carriers and noncarriers, the HR for earlier natural menopause in carriers was 1.45 (95% CI, 1.09-1.94). The second oldest birth cohort, however, demonstrated a decreased HR (0.67 [95% CI, 0.46-0.98]), and thus no trend over birth cohorts was found. Conclusions: Various types of selection bias hamper the comparison of ANM between BRCA1/2 mutation carriers and noncarriers, genetically tested in the clinic.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1097/gme.0000000000000633
الإتاحة: https://doi.org/10.1097/gme.0000000000000633Test
https://journals.lww.com/00042192-201608000-00015Test
رقم الانضمام: edsbas.AB655B36
قاعدة البيانات: BASE